Original Articles Open access

Intimate partner violence in reproductive-age and pregnant-postpartum women with autoimmune rheumatic diseases: a comparative cross-sectional study

Authors

Published
12 June 2025
Section
Original Articles

Abstract

Objective. We aimed to describe the frequency of intimate partner violence (IPV) in reproductive-age women and pregnant-postpartum women with autoimmune rheumatic diseases (ARDs) and compare it with those without ARDs (controls).

Methods. A descriptive, cross-sectional, and comparative study was conducted among pregnant-postpartum patients and reproductive-age women (18-45 years) with and without ARDs who attended the Hospital Universitario in Monterrey, Mexico, and answered the survey Hurt-Insult-Threaten-Scream (HITS) scale in the validated Spanish version, from June 2023 to May 2024.

Results. A total of 120 women were included: 60 with ARDs and 60 controls. In both groups, 30 patients were reproductive-age women and 30 were pregnant-postpartum women. A total of 44 (36%) women reported being victims of IPV. No significant differences were found in reported IPV between the control group and the group of women with ARDs (n=21, 35% vs. n=23, 38%, p=0.85). There was no statistically significant difference between the ARD group compared to the control group in the HITS score (p=0.537), nor between the pregnant-postpartum subgroups (p=0.356) or the reproductive-age subgroups (p=0.972). These findings indicate that IPV rates did not significantly differ by ARD status or reproductive stage in this sample.

Conclusions. Nearly one in every three women experienced IPV, but our research showed that there was no difference in the frequency of IPV between the ARD group and the control group. Pregnant and postpartum women were more likely to report IPV than women of reproductive age. These findings highlight that IPV is a significant concern for all women in Mexico and the need for increased attention and support for them.

Ethics Approval

The research protocol was approved by the Research and Ethics Committee of the Hospital Universitario “Dr. José Eleuterio González” with registration number RE18-00008.

References

  1. Breiding MJ, Basile KC, Smith SG, Black MC, Mahendra RR. Intimate partner violence surveillance: uniform definitions and recommended data elements, version 2.0. 2015. Available from: https://stacks.cdc.gov/view/cdc/31292.
  2. Lutgendorf MA. Intimate partner violence and women’s health. Obstet Gynecol 2019; 134: 470-80. DOI: https://doi.org/10.1097/AOG.0000000000003326
  3. Instituto Nacional de Estadística y Geografía. Encuesta nacional sobre la dinámica de las relaciones en los hogares (ENDIREH) 2021. Available from: https://www.inegi.org.mx/programas/endireh/2021/.
  4. Miller E, McCaw B. Intimate partner violence. N Engl J Med 2019; 380: 850-57. DOI: https://doi.org/10.1056/NEJMra1807166
  5. Ploesser M, Silverman S, Lomeli Diaz JD, Zincke MT, Taylor MB. The link between traumatic stress and autoimmune rheumatic diseases: A systematic scoping review. Semin Arthritis Rheum 2024; 69:152558 DOI: https://doi.org/10.1016/j.semarthrit.2024.152558
  6. Campos-Tinajero E, Ortiz-Nuño MF, Flores-Gutierrez D, Esquivel-Valerio J, García-Arellano G, Cardenas-De la Garza J, et al. Impact of intimate partner violence on quality of life and disease activity in women with systemic lupus erythematosus. Lupus 2024; 33: 979-85. DOI: https://doi.org/10.1177/09612033241260227
  7. Curry SJ, Krist AH, Owens DK, Barry MJ, Caughey AB, Davidson KW, et al. Screening for intimate partner violence, elder abuse, and abuse of vulnerable adults: US Preventive Services Task Force final recommendation statement. JAMA 2018; 320: 1678-87. DOI: https://doi.org/10.1001/jama.2018.14741
  8. Chandan JS, Thomas T, Raza K, Bradbury-Jones C, Taylor J, Bandyopadhyay S, et al. Intimate partner violence and the risk of developing fibromyalgia and chronic fatigue syndrome. J Interpers Violence 2021; 36: 12279-98. DOI: https://doi.org/10.1177/0886260519888515
  9. Campbell KA, Ford-Gilboe M, Stanley M, and Mackinnon, K. Intimate partner violence and women living with episodic disabilities: a scoping review protocol. Syst Rev 2022; 11: 97. DOI: https://doi.org/10.1186/s13643-022-01972-x
  10. Ruiz-Pérez I, Plazaola-Castaño J, Cáliz-Cáliz R, Rodríguez-Calvo I, García-Sánchez A, Ferrer-González MA, et al. Risk factors for fibromyalgia: the role of violence against women. Clin Rheumatol 2009; 28: 777-86. DOI: https://doi.org/10.1007/s10067-009-1147-6
  11. Chen PH, Rovi S, Vega M, Jacobs A, Johnson MS. Screening for domestic violence in a predominantly Hispanic clinical setting. Fam Pract 2005; 22: 617-23. DOI: https://doi.org/10.1093/fampra/cmi075
  12. Sherin KM, Sinacore JM, Li XQ, Zitter RE, Shakil A. HITS: a short domestic violence screening tool for use in a family practice setting. Fam Med 1998; 30: 508-12.
  13. Aletaha D, Neogi T, Silman AJ, Funovits J, Felson DT, Bingham CO 3rd, et al. 2010 Rheumatoid arthritis classification criteria: an American College of Rheumatology/European League Against Rheumatism collaborative initiative. Arthritis Rheum 2010; 62: 2569-81. DOI: https://doi.org/10.1002/art.27584
  14. Aringer M, Costenbader K, Daikh D, Brinks R, Mosca M, Ramsey-Goldman R, et al. 2019 European League against Rheumatism/American College of Rheumatology Classification Criteria for Systemic Lupus Erythematosus. Arthritis Rheumatol 2019; 71: 1400-12. DOI: https://doi.org/10.1002/art.40930
  15. Barbhaiya M, Zuily S, Naden R, Hendry A, Manneville F, Amigo M-C, et al. The 2023 ACR/EULAR Antiphospholipid Syndrome Classification Criteria. Arthritis Rheumatol 2023; 75: 1687-702. DOI: https://doi.org/10.1002/art.42624
  16. Lundberg IE, Tjärnlund A, Bottai M, Werth VP, Pilkington C, de Visser M, et al. 2017 European League against Rheumatism/American College of Rheumatology classification criteria for adult and juvenile idiopathic inflammatory myopathies and their major subgroups. Arthritis Rheumatol 2017; 69: 2271-82. DOI: https://doi.org/10.1136/annrheumdis-2017-212786
  17. van den Hoogen F, Khanna D, Fransen J, Johnson SR, Baron M, Tyndall A, et al. 2013 classification criteria for systemic sclerosis: an American College of Rheumatology/European League against Rheumatism collaborative initiative. Arthritis Rheum 2013; 65: 2737-47. DOI: https://doi.org/10.1002/art.38098
  18. Pyo JY, Lee LE, Park YB, Lee SW. Comparison of the 2022 ACR/EULAR classification criteria for antineutrophil cytoplasmic antibody-associated vasculitis with previous criteria. Yonsei Med J 2023; 64: 11-7. DOI: https://doi.org/10.3349/ymj.2022.0435
  19. Sugg N. Intimate partner violence: prevalence, health consequences, and intervention. Med Clin North Am 2015; 99: 629-49. DOI: https://doi.org/10.1016/j.mcna.2015.01.012
  20. Castro I, Barrantes F, Tuna M, Cabrera G, Garcia C, Recinos M,et al. Prevalence of abuse in fibromyalgia and other rheumatic disorders at a specialized clinic in rheumatic diseases in Guatemala City. J Clin Rheumatol 2005; 11: 140-5. DOI: https://doi.org/10.1097/01.rhu.0000164823.78761.a2
  21. Dokkedahl SB, Kirubakaran R, Bech-Hansen D, Kristensen TR, Elklit A. The psychological subtype of intimate partner violence and its effect on mental health: a systematic review with meta-analyses. Syst Rev 2022; 11: 163. DOI: https://doi.org/10.1186/s13643-022-02025-z
  22. Román-Gálvez RM, Martín-Peláez S, Fernández-Félix BM, Zamora J, Khan KS, Bueno-Cavanillas A. Worldwide prevalence of intimate partner violence in pregnancy. A systematic review and meta-analysis. Front Public Health 2021; 30: 738459. DOI: https://doi.org/10.3389/fpubh.2021.738459
  23. Pastor-Moreno G, Ruiz-Pérez I, Henares-Montiel J, Escribà-Agüir V, Higueras-Callejón C, Ricci-Cabello I. Intimate partner violence and perinatal health: a systematic review. BJOG 2020; 127: 537-47. DOI: https://doi.org/10.1111/1471-0528.16084
  24. Williams A, Grantz K, Seeni I, Robledo C, Li S, Ouidir M, et al. Obstetric and neonatal complications among women with autoimmune disease. J Autoimmun 2019; 103: 102287. DOI: https://doi.org/10.1016/j.jaut.2019.05.015
  25. Filippini M, Fontana G, Bizioli P, Crisafulli F, Orabona R, Zatti S, et al. Pregnancy in patients affected by axial-spondyloarthritis: a narrative review of disease activity and obstetric outcomes. Reumatismo 2024; 76: 1697. DOI: https://doi.org/10.4081/reumatismo.2024.1697
  26. Mason SM, Wright RJ, Hibert EN, Spiegelman D, Jun H, Hu FB, et al. Intimate partner violence and incidence of type 2 diabetes in women. Diabetes Care 2013; 36: 1159-65. DOI: https://doi.org/10.2337/dc12-1082
  27. Modesitt SC, Gambrell AC, Cottrill HM, Hays LR, Walker R, Shelton BJ, et al. Adverse impact of a history of violence for women with breast, cervical, endometrial, or ovarian cancer. Obstet Gynecol 2006; 107: 1330-6. DOI: https://doi.org/10.1097/01.AOG.0000217694.18062.91
  28. Kendall T, van Dijk M, Wilson KS, Picasso N, Lara D, Garcia S. A lifetime of violence: results from an exploratory survey of Mexican women with HIV. J Assoc Nurses AIDS Care 2012; 23: 377-87. DOI: https://doi.org/10.1016/j.jana.2011.11.007
  29. Wuest J, Merritt-Gray M, Ford-Gilboe M, Lent B, Varcoe C, Campbell JC. Chronic pain in women survivors of intimate partner violence. J Pain 2008; 9: 1049-57. DOI: https://doi.org/10.1016/j.jpain.2008.06.009
  30. Pawlak CR, Jacobs R, Mikeska E, Ochsmann S, Lombardi MS, Kavelaars A, et al. Patients with systemic lupus erythematosus differ from healthy controls in their immunological response to acute psychological stress. Brain Behav Immun 1999; 13: 287-302. DOI: https://doi.org/10.1006/brbi.1999.0553
  31. Jacobs R, Pawlak CR, Mikeska E, Meyer‐Olson D, Martin M, Heijnen CJ, et al. Systemic lupus erythematosus and rheumatoid arthritis patients differ from healthy controls in their cytokine pattern after stress exposure. Rheumatology 2001; 40: 868-75. DOI: https://doi.org/10.1093/rheumatology/40.8.868

Metrics

Citations and online attention from Dimensions, Altmetric and PlumX.